Cost-Utility Analysis of Landmark CO.21 CHALLENGE Trial Shows Exercise Programs Can Also Reduce Health System Costs

In a groundbreaking development for oncology and preventive health, new findings presented in early August 2026 demonstrate that a structured exercise program for colon cancer survivors not only improves survival outcomes but also significantly reduces healthcare system costs.
Researchers with the Canadian Cancer Trials Group (CCTG) examined the economic impact of integrating structured physical activity into follow-up care for patients with curable colon cancer. The economic analysis of the landmark CCTG CO.21 CHALLENGE trial was published in the Journal of Clinical Oncology, providing robust evidence that structured exercise yields positive long-term outcomes at a fraction of the cost of traditional medical interventions.
A Standard Anti-Cancer Treatment
"We now have both clinical and economic evidence to inform the adoption and integration of a structured exercise program into routine clinical care," stated Dr. Kelvin Chan, medical oncologist at Sunnybrook’s Odette Cancer Centre and CCTG Committee on Economic Analysis Co-Chair. He emphasized that structured exercise should no longer be viewed merely as an optional lifestyle choice, but as a standard anti-cancer treatment for patients following adjuvant chemotherapy.
The cost of the exercise program involves personal trainers meeting with patients every two weeks in the first year, and monthly in the second and third years. The total cost for this comprehensive program is approximately $3,000 per person. This figure is highly affordable when compared with most new cancer medicines, which frequently exceed $200,000 per year.
Official Research Announcement
Canadian Cancer Trials Group Official Report:
New findings demonstrate that a structured exercise program for colon cancer survivors improves survival outcomes and reduces healthcare system costs. The economic analysis of the landmark CCTG CO.21 CHALLENGE trial was presented at ASCO 2026 and published in the Journal of Clinical Oncology.
Reducing the Economic Burden of Care
Because the exercise program reduces the number of patients who develop recurrent cancer, it ultimately saves more money than it costs. This is achieved through a substantial decrease in future chemotherapy and other healthcare expenses. The cost-utility analysis sought to determine the incremental cost, incremental quality-adjusted life years (QALYs), and cost-utility ratio of the structured exercise program plus health educational materials versus educational materials alone.
"The economic analysis shows that the exercise program is one of the very rare health care interventions that both improves survival AND reduces health system spending," noted Dr. Christopher Booth, CO.21 study co-lead and Professor of Oncology at Queen’s University. He stressed the urgent need for health systems and payers to ensure patients have access to these services in routine clinical care.
These results add to a growing body of research supporting patient-centered interventions that improve outcomes while helping to reduce the economic burden of cancer care. By reinforcing that delivering a structured exercise program improves patient outcomes and reduces overall healthcare costs, this analysis provides a compelling blueprint for more equitable and sustainable access to effective care globally.




Comments (0)
No comments yet. Be the first to share your thoughts!
Want to join the discussion?
Please log in to post a comment.
Login NoworCreate an Account